Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,303.00    -20.00 (-0.86%)
Bid:
2,305.00
Ask:
2,308.00
Spread: 3.00 (0.13%)
Market Cap: £23.26b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Transaction in Own Shares

13 Jun 2014 15:24

RNS Number : 6264J
3i Group PLC
13 June 2014
 



13 June 2014

3i Group plc

Repurchase and cancellation of B Shares

On 14 May 2014, 3i Group plc (the "Company") announced that the Company had made arrangements with Merrill Lynch International ("MLI") for MLI to offer to purchase all the issued B Shares for cash at a price of 131.4364 pence per B Share.

Following MLI's acquisition of the B Shares under the terms announced on 14 May 2014, MLI has today exercised its right to require the Company to purchase from MLI all the B Shares and the Company has consequently repurchased all 4,635,018 B Shares from MLI for 131.4364 pence per B Share. The Company confirms that all the B Shares will be cancelled and not held as treasury shares.

 

Following the cancellation of the B Shares, which is expected to be effective on 17 June 2014, no B Shares will remain in issue. The Company will then request the listing cancellation of the B Shares which is expected to occur on or shortly after 18 June 2014.

 For further information, contact:

Kathryn van der Kroft, Communications Director

Tel: +44 20 7975 3021

Silvia Santoro, Investor Relations Director

Tel: +44 20 7975 3258

 

Notes to editors:

1. 3i is a leading international investor focused on mid-market private equity, infrastructure and debt management. For further information please refer to www.3i.com.

2. The Company issued B Shares in 2006 and 2007 as part of arrangements to return value to shareholders. A number of offers to purchase these B Shares were made in 2006 to 2009 which gave shareholders flexibility as to when they received the proceeds of the return of value and, in certain cases, as to whether the proceeds represented income or capital. The terms of issue of the B Shares allowed the Company to arrange for all outstanding B Shares to be purchased at any time after July 2009 and it was always intended that this would be done at an appropriate time. On 14 May 2014 the Company announced that arrangements had been made for such a purchase of all outstanding B shares.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSZMGMVDFGGDZM
Date   Source Headline
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 202611:21 amRNSDirector/PDMR Shareholding
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:00 pmRNSHolding(s) in Company
2nd Jun 20264:24 pmRNSDirector/PDMR Shareholding
2nd Jun 20263:37 pmRNSDirector/PDMR Shareholding - Amendment
1st Jun 20264:28 pmRNSDirector/PDMR Shareholding
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:42 pmRNSTotal Voting Rights
29th May 20265:38 pmRNSAdmission to Trading
27th May 202610:42 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 202612:29 pmRNSDirector/PDMR Shareholding
21st May 20267:40 amRNSDoc re. 2026 Annual Report and Accounts
19th May 20262:28 pmRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202610:24 amRNSDirector/PDMR Shareholding
14th May 202610:41 amRNSHolding(s) in Company
14th May 20267:02 amRNSCommencement of Share Buyback Programme
14th May 20267:00 amRNSResults for the year to 31 March 2026
1st May 202612:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:34 pmRNSTotal Voting Rights
30th Apr 20263:31 pmRNSAdmission to Trading
7th Apr 202612:33 pmRNSHolding(s) in Company
1st Apr 20269:53 amRNSPortfolio Update
1st Apr 20269:36 amRNSDirector/PDMR Shareholding
31st Mar 20262:30 pmRNSTotal Voting Rights
31st Mar 20262:29 pmRNSAdmission to Trading
31st Mar 202611:37 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:07 pmRNSAdmission to Trading
26th Mar 20267:00 amRNSAction Capital Markets Seminar & portfolio update
23rd Mar 202612:11 pmRNSHolding(s) in Company
2nd Mar 202612:18 pmRNSDirector/PDMR Shareholding
27th Feb 20264:00 pmRNSTotal Voting Rights
3rd Feb 202610:20 amRNSHolding(s) in Company
3rd Feb 202610:17 amRNSDirector Declaration
30th Jan 20262:24 pmRNSDirector/PDMR Shareholding
30th Jan 20261:47 pmRNSTotal Voting Rights
29th Jan 202612:19 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSFY2026 Q3 performance update
7th Jan 20262:06 pmRNSDirector/PDMR Shareholding
6th Jan 20261:53 pmRNSTotal Voting Rights
2nd Jan 202611:06 amRNSPortfolio Update
9th Dec 20251:11 pmRNSBlock listing Interim Review
4th Dec 20252:12 pmRNSDirector/PDMR Shareholding
1st Dec 20251:25 pmRNSDirector/PDMR Shareholding
28th Nov 20254:24 pmRNSTotal Voting Rights
20th Nov 20259:59 amRNSDirector/PDMR Shareholding
18th Nov 20252:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.